Results 291 to 300 of about 75,748 (340)

Cardiovascular biomarkers and preeclampsia: A narrative review

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Preeclampsia (PE) is a complex pregnancy disorder linked to cardiovascular disease (CVD) through shared risk factors and epidemiological associations. Cardiovascular biomarkers are valuable for predicting, diagnosing and assessing PE, as well as estimating future CVD risk. This review explores current cardiovascular biomarkers used in clinical practice
Johana Ullmo, Madalina Nicoleta Nan, Mónica Cruz‐Lemini, Carmen Garrido‐Gimenez, Judit Platero, Álvaro García‐Osuna, Pablo García‐Manau, Marcel Twickler, Elisa Llurba   +8 more
wiley   +1 more source

Implications of inflammation and sex in lower extremity arterial disease

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
The graphical abstract illustrates the role of inflammation and sex‐related differences in lower extremity artery disease (LEAD). Key inflammatory biomarkers associated with LEAD include C‐reactive protein (CRP), fibrinogen, interleukin‐6 (IL‐6), and D‐dimer, which contribute to vascular inflammation and atherosclerotic plaque formation in lower limb ...
Katja Schnidrig, Manovriti Thakur, Aleksandra Tuleja, Sarah Maike Bernhard, Heidi Noels, Drosos Kotelis, Marc Schindewolf, Yvonne Döring   +7 more
wiley   +1 more source

Prognostic value of NT-proBNP in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair. [PDF]

Eur J Heart Fail
von Stein P, Weimann J, Pfister R, Ludwig S, Koell B, Donal E, Patel D, Stolz L, Tanaka T, Scotti A, Trenkwalder T, Rudolph F, Samim D, Giannini C, Dreyfus J, Paradis JM, Adamo M, Karam N, Bohbot Y, Bernard A, Melica B, Quagliana A, Badie YL, Kessler M, Chehab O, Redwood S, Lubos E, Sondergaard L, Metra M, Primerano C, Praz F, Gerçek M, Xhepa E, Nickenig G, Latib A, Schofer N, Makkar R, Granada JF, Modine T, Hausleiter J, Coisne A, Kalbacher D, Iliadis C, on behalf of the PRIME‐MR Investigators.   +43 more
europepmc   +1 more source

IL‐6 in the spotlight: From cardiovascular pathophysiology to therapy

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Interleukin‐6 (IL‐6) links inflammation to cardiovascular and multi‐organ dysfunction. This review integrates mechanistic, translational, and clinical evidence supporting IL‐6 as both a biomarker and therapeutic target in the continuum of cardiovascular and cardio‐renal disease.
Alberto Preda, Amedeo Tirandi, Giulio Leo, Davide Di Vece, Gemma Vilahur, Aldo Bonaventura, Elena Osto, Stefano Ministrini, Simon Kraler, Petra Kleinbogard, Giovanni Camici, Federico Carbone, Fabrizio Montecucco, Luca Liberale   +13 more
wiley   +1 more source

Clinical significance of a machine learning model based on short-term changes in NT-proBNP after TAVR. [PDF]

Int J Cardiol Heart Vasc
Mao Y, Zhai M, Jin P, Zhang G, Zhang H, Wei L, Shang X, Liu J, Guo Y, Pan X, Liu Y, Yang J.   +11 more
europepmc   +1 more source

Troponin, NT-proBNP and postoperative atrial fibrillation in a prospective cohort undergoing coronary artery bypass surgery. [PDF]

Sci Rep
Ohlrogge AH, Seum F, Ruhland K, Ojeda FM, Börschel CS, Pecha S, Blankenberg S, Zeller T, Schnabel RB.   +8 more
europepmc   +1 more source

Refining cardiovascular risk prediction after renal transplantation: a cross-sectional study focusing on NT-proBNP and the revised cardiac risk index. [PDF]

Perioper Med (Lond)
Moghaddasfar T, Beiranvandi F, Mehrpooya M, Bahramrafiee R, Geraiely B, Larti F, Khatami SMR.   +6 more
europepmc   +1 more source

Prognostic value of NT-proBNP and uric acid in acute ST-segment elevation myocardial infarction patients after complete revascularization

Kang Li
openalex   +1 more source